112 related articles for article (PubMed ID: 9972368)
1. Kinetics of 111In-labeled bleomycin in patients with brain tumors: compartmental vs. non-compartmental models.
Ryynänen PM; Savolainen SE; Aronen HJ; Korppi-Tommola ET; Huhmar HM; Kallio ME; Hiltunen JV
Ann Nucl Med; 1998 Dec; 12(6):313-21. PubMed ID: 9972368
[TBL] [Abstract][Full Text] [Related]
2. 111In-labelled bleomycin complex for the differentiation of high- and low-grade gliomas.
Korppi-Tommola T; Huhmar H; Aronen HJ; Penttilä P; Hiltunen J; Savolainen S; Kallio ME; Liewendahl K
Nucl Med Commun; 1999 Feb; 20(2):145-52. PubMed ID: 10088163
[TBL] [Abstract][Full Text] [Related]
3. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.
Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM
J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427
[TBL] [Abstract][Full Text] [Related]
4. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.
Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE
Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096
[TBL] [Abstract][Full Text] [Related]
5. Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex.
Hou DY; Maruyama Y
J Surg Oncol; 1990 May; 44(1):5-9. PubMed ID: 1692949
[TBL] [Abstract][Full Text] [Related]
6. Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC.
Hou DY; Hamburger AW; Beach JL; Maruyama Y
Cancer Invest; 1989; 7(6):543-50. PubMed ID: 2483533
[TBL] [Abstract][Full Text] [Related]
7. Biokinetics of indium-111-bleomycin complex in head and neck cancer--implementations for radiochemotherapy.
Kairemo KJ; Ramsay HA; Paavonen TK; Jääskelä-Saari HA; Tagesson M; Ljunggren K; Strand SE
Cancer Detect Prev; 1997; 21(1):83-90. PubMed ID: 9043768
[TBL] [Abstract][Full Text] [Related]
8. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy.
Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM
J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055
[TBL] [Abstract][Full Text] [Related]
9. Imaging of olfactory neuroblastoma by In-111 bleomycin complex.
Jekunen AP; Kairemo KJ; Ramsay HA; Kajanti MJ
Clin Nucl Med; 1996 Feb; 21(2):129-31. PubMed ID: 8697683
[TBL] [Abstract][Full Text] [Related]
10. A low pH 111In-bleomycin complex: a tracer for radiochemotherapy of head and neck cancer.
Kairemo KJ; Ramsay H; Nikula TK; Hopsu EV; Taavitsainen MJ; Bondestam S; Hiltunen JV
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):135-9. PubMed ID: 7543289
[TBL] [Abstract][Full Text] [Related]
11. A new 111In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice.
Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE
J Surg Oncol; 1984 Mar; 25(3):168-75. PubMed ID: 6199622
[TBL] [Abstract][Full Text] [Related]
12. Imaging and staging of head and neck cancer using a low pH In-111-bleomycin complex.
Kairemo KJ; Ramsay HA; Paavonen T; Bondestam S
Eur J Cancer B Oral Oncol; 1996 Sep; 32B(5):311-21. PubMed ID: 8944834
[TBL] [Abstract][Full Text] [Related]
13. Distribution of 111In-bleomycin complex in small cell lung cancer cells by autoradiography.
Hou DY; Maruyama Y
J Surg Oncol; 1992 Feb; 49(2):93-7. PubMed ID: 1371176
[TBL] [Abstract][Full Text] [Related]
14. Chromosome aberrations of human small cell lung cancer induced by a new 111In-bleomycin complex.
Hou DY; Maruyama Y; Drago JR
J Surg Oncol; 1992 Dec; 51(4):236-42. PubMed ID: 1279317
[TBL] [Abstract][Full Text] [Related]
15. Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex.
Hou DY; Ordonez JV; Cross RJ; Ross DD; Maruyama Y
J Surg Oncol; 1989 Feb; 40(2):73-8. PubMed ID: 2464720
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell cancer cell lines: sensitivity to bleomycin and suitability for animal xenograft studies.
Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R
Acta Otolaryngol Suppl; 1997; 529():241-4. PubMed ID: 9288321
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
Konikowski T; Haynie TP; Glenn HJ
J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
[TBL] [Abstract][Full Text] [Related]
18. Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.
Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
Eur J Nucl Med; 1983; 8(12):535-40. PubMed ID: 6199207
[TBL] [Abstract][Full Text] [Related]
19. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
20. Use of 111In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice.
Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
J Surg Oncol; 1985 Jun; 29(2):71-7. PubMed ID: 2417054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
